SpyGlass Pharma Balance Sheet (2024-2026) | SGP

Balance Sheet Dec2024 Dec2025 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter) 16.27M96.36M223.14M
Receivables - Other (Quarter) 0.42M0.43M0.68M
Prepaid Assets (Quarter) 0.71M0.90M1.60M
Current Assets (Quarter) 17.41M108.77M236.46M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 2.17M2.34M4.79M
Other Non-Current Assets (Quarter) 0.45M0.49M0.76M
Non-Current Assets (Quarter) 5.91M7.10M6.97M
Assets (Quarter) 23.32M115.87M243.43M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 1.98M2.70M4.16M
Payables (Quarter) 1.98M2.70M4.16M
Accumulated Expenses (Quarter) 1.28M2.18M1.72M
Other Accumulated Expenses (Quarter) 0.67M3.71M3.56M
Current Leases (Quarter) 0.44M
Total Current Liabilities (Quarter) 7.79M8.58M9.44M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 72.55M204.54M
Operating Leases (Quarter) 3.46M1.57M1.63M
Total Liabilities (Quarter) 11.25M10.17M11.07M
Shareholder's Equity
Common Equity (Quarter) -60.47M-98.84M232.36M
Liabilities and Shareholders Equity (Quarter) 23.32M115.87M243.43M
Retained Earnings (Quarter) -64.86M5.89M370.78M
Treasury Shares (Quarter) 9.61M20.34M